A Look at Upcoming Innovations in Electric and Autonomous Vehicles Federal Judge Halts Rhode Island Cannabis Licensing, Citing Constitutional Residency Barriers

Federal Judge Halts Rhode Island Cannabis Licensing, Citing Constitutional Residency Barriers

A federal preliminary injunction issued April 8 has frozen Rhode Island's long-delayed adult-use cannabis retail licensing process, blocking the Cannabis Control Commission from moving forward with a planned lottery that would have awarded up to 20 new dispensary licenses as early as May. The ruling came after three out-of-state residents - two from California, one from Florida - successfully argued that Rhode Island's requirement that cannabis businesses be 51% owned by an in-state resident violates the U.S. Constitution's Dormant Commerce Clause and the Equal Protection Clause.

A Market That Has Run on Eight Operators for Three-Plus Years

The stakes here are not abstract. Since adult-use sales launched in December 2022, Rhode Island's retail cannabis market has operated through just eight dispensaries - all former medical operators who converted to recreational sales under a transitional provision in the Rhode Island Cannabis Act. Those eight retailers collectively generated roughly $120 million in 2025 cannabis sales, or approximately $15 million per store - the highest per-dispensary revenue rate in the country. That is what new entrants have been waiting, and in many cases preparing for years, to access.

The CCC had received 97 applications for 24 available licenses, distributed across six geographic zones. Each zone offered one slot for a social equity applicant, one for a workers' cooperative, and two general licenses. Twenty of the 24 slots drew applicants; two zones failed to attract interest for both the worker cooperative and general license categories. Then came the injunction, and the lottery went on hold indefinitely.

The Constitutional Argument - and Why It Has Traction

The Dormant Commerce Clause - a judicial doctrine inferred from Congress's enumerated power to regulate interstate commerce - has long been used to strike down state laws that discriminate against out-of-state economic actors. The doctrine's central premise: states cannot erect protectionist barriers that favor their own residents at the expense of a functioning national market. The complication cannabis has always posed is obvious. Cannabis remains a Schedule I controlled substance under federal law, meaning no legal interstate market for it exists. How can a state distort a market that, federally speaking, isn't there?

That question has produced a genuine split among federal appellate courts. The First Circuit ruled in 2022 that Maine's state residency requirement for medical cannabis business owners was unconstitutional - Dormant Commerce Clause fully applicable, Schedule I status notwithstanding. The Second Circuit extended that reasoning to New York's adult-use licensing structure in August 2024, rejecting the state's argument that Congress had effectively blessed protectionist cannabis laws through its silence. The Ninth Circuit, by contrast, ruled in January 2025 that the Dormant Commerce Clause does not apply to cannabis under federal prohibition - a conclusion that, notably, drew heavily on dissenting opinions in the Second Circuit's New York ruling.

Rhode Island's CCC asked U.S. District Judge Melissa R. DuBose to follow the Ninth Circuit. She declined. Rhode Island sits within the First Circuit's jurisdiction, and DuBose found the First Circuit's 2022 Maine decision binding precedent - applicable here because the constitutional logic doesn't meaningfully change whether the market in question is medical or recreational. "The Dormant Commerce Clause applies to the recreational cannabis market," she wrote, flatly.

The circuit split - First and Second on one side, Ninth on the other - is now conspicuous enough that it may eventually compel Supreme Court review. That would force the Court to answer a question it has thus far managed to sidestep: can the federal government's own prohibition on cannabis be cited by states as cover for economic protectionism in cannabis licensing? The answer, whichever way it goes, will reverberate through every state market currently running some version of residency-preference rules.

What This Means for Aspiring Rhode Island Operators

For applicants who went through Rhode Island's application process in good faith - submitting paperwork by the late December deadline, meeting the various social equity, cooperative, and general criteria - the injunction is a hard stop with no clear timeline attached. The CCC's website acknowledges the decision and promises further guidance; the commission's next meeting was scheduled for April 17. Whether that meeting produces anything actionable depends on how the commission's legal team assesses its options.

The thing is, this was already a delayed market. Nearly three and a half years after adult-use sales began, the eight incumbents have had an extraordinary runway - time to build brand recognition, operational scale, and customer loyalty that new entrants will have to work against, not just alongside. A further delay compounds that asymmetry. And the irony is not lost: Rhode Island's licensing framework included social equity provisions and worker cooperative pathways specifically designed to broaden participation. Those provisions are now frozen by a constitutional challenge that argues, at its core, that the state was too narrowly selective about who could participate in the first place.

Whether the injunction holds through litigation, whether the CCC revises its residency criteria to comply with First Circuit precedent, or whether the broader constitutional question travels toward the Supreme Court - any of those paths takes time Rhode Island's aspiring operators don't have an obvious substitute for. The existing eight retailers will keep selling in the meantime. The meter is running.

4/20 EXCLUSIVE DEAL
Don't miss it
42%
OFF Annual Plans This 4/20
For new customers · First year only
IndicaOnline — All-in-One
Cannabis POS & Software Ecosystem
Offer ends in
00Days
00Hrs
00Min
00Sec
Claim Your Discount Now →
Discount applies to annual plans · First year only · New customers
Why dispensaries choose us
Intuitive POS System
Built for cannabis ops. Staff adapts fast, checkout is seamless.
Real-Time Inventory
Audit by category, adjust instantly, prevent discrepancies.
Metrc Compliance
Auto-sync keeps you audit-ready. Full traceability, zero errors.
Delivery & Driver App
Smart routing, cockpit control, real-time driver tracking.
Reports & Analytics
Track sales, inventory, staff. Automated insights, prevent losses.
$7B+
sales
processed
1,000+
dispensary
customers
20+
integrations
included
$240
from/mo
flat price